- 期刊
Successful Treatment with Peginterferon and Ribavirin in a Patient with Acute Hepatitis C Evolving into Chronicity
以常效型干擾素合併雷巴威林成功治療一例急性C型肝炎
並列摘要
Acute hepatitis C has a high frequency of chronic evolution, which may progress to cirrhosis and hepatocellular carcinoma. However, only a small proportion of acute hepatitis C patients are incidentally identified and then treated. Controversial issues regarding treatment of acute hepatitis C include optimal time of treatment initiation, best treatment regimen and appropriate duration of treatment. We report a symptomatic acute hepatitis C patient in the late acute phase evolving into chronicity successfully treated by peginterferon and ribavirin combination therapy for 6 months at late acute phase, with sustained virologic response for up to 18 months. Our findings indicate that combination peginterferon and ribavirin therapy may be as effective in treating acute hepatitis C as it is in chronic hepatitis C.
延伸閱讀
- 許景盛（2005）。慢性C型肝炎病毒感染者於接受長效型干擾素和雷巴威林合併治療前後之早期病毒動力學變化〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2005.03007
- Hwang, S. J., Wang, Y. J., Lee, S. D., Chu, C. J., & Chang, F. Y. (2005). 合併干擾素及口服ribavirin治療單用干擾素無效或復發之慢性C型肝炎. 北市醫學雜誌, 2(3), 254-264. https://doi.org/10.6200/TCMJ.2005.2.3.04
- 黃釧峰（2009）。長效型干擾素合併雷巴威靈在慢性C型肝炎老人患者的療效及安全性研究〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-0107200916554000
- Yeh, M. L. (2019). 慢性B型與C型肝炎合併感染應用長效干擾素合併雷巴威林或全口服直接作用抗病毒藥物治療之世代性研究 [doctoral dissertation, Kaohsiung Medical University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0011-0507201914532600
- 張秋純、林俊哲、陳滋彥、陳丹霞、蔡明璋、楊凱凡、林敬斌、張明輝（2010）。不同療程之長效型干擾素合併雷巴威林治療慢性C型肝炎病毒基因型第一型之療效分析。中山醫學雜誌，21(4)，381-396。https://doi.org/10.30096/CSMJ.201012.0005